Immediate Impact
3 from Science/Nature 55 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
De novo protein design—From new structures to programmable functions
2024 Standout
Works of Caroline Rynn being referenced
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Caroline Rynn | 270 | 170 | 31 | 50 | 12 | 376 | |
| Denis Platel | 226 | 85 | 38 | 24 | 13 | 426 | |
| Xiuhua Wu | 229 | 77 | 16 | 62 | 11 | 434 | |
| Kristoffer Brandvold | 262 | 90 | 10 | 20 | 14 | 373 | |
| Yulia Jitkova | 216 | 98 | 16 | 116 | 19 | 369 | |
| Hiromi Muraoka | 222 | 162 | 49 | 17 | 23 | 409 | |
| P.A. Wright | 228 | 53 | 19 | 62 | 19 | 433 | |
| Guan-Nan Zhang | 241 | 269 | 14 | 19 | 15 | 413 | |
| Csilla Hegedüs | 212 | 346 | 18 | 32 | 13 | 435 | |
| Chris J. Radoux | 307 | 79 | 64 | 38 | 9 | 402 | |
| Sharon Sokolowski | 124 | 160 | 69 | 16 | 10 | 366 |
All Works
Login with ORCID to disown or claim papers
Loading papers...